Posted in | News

PetroChina to Use Basell Technology for 3 New Polypropylene Plants

Apr 4 2003

Related Stories

PetroChina and Bassel have just signed a licensing agreement that will see PetroChina use Bassel’s Spheripol technology in three new polypropylene plants.

The new plants with a combined capacity of 800,000 tonnes per year will be built in Daqing, Lanzhou and Dalian in the People’s Republic of China. The former two plants will have capacities of 300,000 tonnes per year, while the Dalian plant will have a capacity of 200,000 tonner per year.

The Spheripol technology which has been constantly improved and upgraded has been used in almost half of all new polypropylene plants built across the world over the last 20 years.

For more information on polypropylene, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback